Clinical Trials Directory

Trials / Completed

CompletedNCT02899234

Acute Cardiorespiratory Effects of E-cigarette Inhalation

Acute Health Effects of Exposure to Active E-cigarette Inhalation in Healthy Volunteers

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
19 (actual)
Sponsor
Umeå University · Academic / Other
Sex
All
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

According to the World Health Organization cigarette smoking is today one of the leading single causes of preventable death and morbidity. The electronic cigarette (e-cigarette) has been marketed as a safer alternative to conventional cigarettes, and its global sales continue to grow exponentially each year. Despite growing e-cigarette use, scientific data on health effects are insufficient in some respects and completely lacking in others. Therefore the current study is designed to investigate the effects of active e-cigarette inhalation on the cardiovascular and respiratory systems.

Detailed description

It is estimated that 6 million people worldwide lose their lives due to tobacco use yearly. On average, cigarette smokers are estimated to die 10 years earlier than non-smokers. Ischemic heart disease, chronic obstructive pulmonary disease, stroke, respiratory illness, lung cancer and other cancers have all been linked to tobacco use. In recent years the electronic cigarette (e-cigarette) has been introduced to the market as an alternative to traditional cigarette smoking. E-cigarettes have been aggressively marketed as a cheaper, healthier, cleaner alternative to smoking in both advertising and media outlets, primarily targeting women and adolescents. With limited knowledge of e-cigarette vaping health effects in humans it has been challenging for governments and health officials to give advice and regulate the use of this novel product. In the current study investigators aim to investigate acute cardiovascular and respiratory effects after active inhalation of e-cigarette in healthy human subjects.

Conditions

Interventions

TypeNameDescription
OTHERE-cigaretteA third generation e-cigarette device will be used with pre-determined temperature, voltage and wattage settings.

Timeline

Start date
2016-09-01
Primary completion
2018-05-01
Completion
2018-06-01
First posted
2016-09-14
Last updated
2018-10-04

Locations

1 site across 1 country: Sweden

Source: ClinicalTrials.gov record NCT02899234. Inclusion in this directory is not an endorsement.